NeoGenomics Corp (NEO) Kompaniya qiymatining sof foydaga nisbati
NeoGenomics, Inc. (NEO) aniqlik onkologiya diagnostikasi segmentida yetakchi pozitsiyaga ega bo'lib, B2B sektoriga genetik testlarning keng ko'lamini taklif etadi. P/E koeffitsiyenti tarixi aktivning bozor qiymatini ko'rsatadi, bunda joriy ko'rsatkich -70.40 ni tashkil etadi. Kompaniya AQSh tibbiyot markazlariga chuqur integratsiyadan foydalangan holda, shifokorlar uchun o'simta tahlili va sog'liqni saqlash gigantlari uchun klinik sinovlar orqali daromad keltiradi.
%20Narx-foyda%20koeffitsiyenti&width=1200&height=400&colorIndex=0&v=mwa76aez.ocr-7cpmfb4&start=20220704&end=20261110&filename=GURU_Markets_-_NEO_-_NeoGenomics-Inc._-_Price-to-Earnings-Ratio "NEO - NeoGenomics, Inc. Kapitalizatsiyaning foydaga nisbati 04.07.2022 - 10.11.2026 oraligʻida | 👁️GURU.Markets👁️")
NeoGenomics, Inc. kompaniyasining tahliliy kesimlari
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi tafsilotlari:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning kapitalga nisbati NeoGenomics, Inc.|NEO - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli majburiyatlarning kapitalga nisbati NeoGenomics Corp|NEO - Kompaniyaning jamlangan qarzlari|Qarzning sof aktivlarga nisbati NeoGenomics, Inc.|NEO - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz NeoGenomics|Shoshilinch likvidlik koeffitsiyenti neogenomics.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
NEO - Kompaniyaning sof foydasi|Kutilayotgan sof foyda NeoGenomics, Inc.|NEO - Narxning foydaga nisbati|Prognoz qilingan narxning foydaga nisbati NeoGenomics Inc|NEO - PEG multiplikatori|Kompaniyaning to‘liq qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati NeoGenomics, Inc.|NEO - EBITDA operatsion foydasi|So'nggi 12 oy davomida bir aksiya uchun sof foyda NeoGenomics|NEO - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi o'n ikki oy davomida bir aksiya uchun sof foydaning yillik o'zgarishi neogenomics.com|NEO - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yilda bir aksiya uchun foydaning kutilayotgan dinamikasi NeoGenomics, Inc.
Kompaniyaning jamlanma tahlili:NEO - neogenomics.com
NeoGenomics, Inc. (NEO) kompaniyasida onkologik diagnostika sohasidagi masshtab iqtisodiyoti birlik xarajatlarini kamaytiradi, bu esa bevosita aksiya uchun foydani oshiradi. Emitentning P/E tarixini tahlil qilish orqali investor biznesning bozor qiymatini uning haqiqiy daromadlariga nisbatan baholaydi, bu esa aktivlarning haddan tashqari qimmat baholanganlik darajasini aniqlash va narx-foyda koeffitsiyenti orqali kompaniyaning fundamental barqarorligini tasdiqlash imkonini beradi.
Muhim raqobatchilar
LIN (linde.com) - Bozor narxining sof foydaga nisbati|Narxning foydaga nisbati Air Products and Chemicals (APD)|DD (DuPont de Nemours) - Kompaniya qiymatining sof foydaga nisbati|International Paper Corp - Narx-foyda koeffitsiyenti|PPG Paints (PPG) - Kapitalizatsiyaning foydaga nisbati|DOW - Narxning foydaga nisbati|LYB (lyondellbasell.com) - Narx-foyda multiplikatori|IFF: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati RPM International Inc (RPM)|Narxning foydaga nisbati Entegris Corp|Kapitalizatsiyaning foydaga nisbati Suzano Group SUZ|P/E multiplikatori WLK|albemarle.com (ALB) - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|P/E multiplikatori ICL (ICL Group)|NewMarket Corp (NEU) - Kapitalizatsiyaning foydaga nisbati|EMN - Narxning foydaga nisbati|AXTA (Axalta Corp) - Narx-foyda multiplikatori|Element Solutions Inc (ESI) - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati sqm.com (SQM)|Narxning foydaga nisbati Celanese|Narx-foyda koeffitsiyenti Sensient Technologies Corporation (SXT)|P/E multiplikatori CBT|Biznesning o‘zini qoplash muddati Hawkins Corp|P/E multiplikatori AVNT (Avient Corporation)|FUL - Narx-foyda koeffitsiyenti|MEOH - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati WD-40 Co. WDFC|CC (Chemours Corp) - Narx-foyda koeffitsiyenti|Quaker Chemical Corp. - Kompaniya qiymatining sof foydaga nisbati|PCT (PureCycle Technologies) - P/E multiplikatori|ashland.com (ASH) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Ingevity (NGVT)|Innospec Inc - Narx-foyda multiplikatori|P/E multiplikatori MTX (Minerals Tech)|DQ - Narx-foyda koeffitsiyenti|SLVM: Narx-foyda koeffitsiyenti|Biznesning o‘zini qoplash muddati huntsman.com HUN|Albany International Corp. (AIN) - Narxning foydaga nisbati|Narx-foyda multiplikatori CLMT|ROG (Rogers Advanced Electronics) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Stepan Chemical SCL|Narxning foydaga nisbati Ecovyst Inc. (ECVT)|REX - Kapitalizatsiyaning foydaga nisbati|P/E multiplikatori ASPI (ASP Isotopes)|TROX - Narx-foyda koeffitsiyenti|Ferroglobe Corp - P/E multiplikatori|Kompaniya qiymatining sof foydaga nisbati WLKP (Westlake Partners)|CMP: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati kronostio2.com (KRO)|Narxning foydaga nisbati Mativ|Narx-foyda koeffitsiyenti LSB Industries Inc (LXU)|P/E multiplikatori BAK|Biznesning o‘zini qoplash muddati Koppers Corp|Narxning foydaga nisbati AdvanSix Inc. ASIX|Biznesning o‘zini qoplash muddati orioncarbons.com (OEC)|RYAM: Narx-foyda koeffitsiyenti|Aduro Clean Tech - Bozor narxining sof foydaga nisbati|Magnera Inc. (MAGN) - Narxning foydaga nisbati|Clearwater Paper Corp. - Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti TG|Kapitalizatsiyaning foydaga nisbati coremt.com CMT|Narxning foydaga nisbati FutureFuel (FF)|flexiblesolutions.com - Narx-foyda multiplikatori|P/E multiplikatori ALTO (Alto Ingredients)|5E Advanced Materials Inc (FEAM) - Kapitalizatsiyaning foydaga nisbati|TSE - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati Origin Materials, Inc.|NTIC: P/E multiplikatori|Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti LanzaTech Global LNZA|YMAT (J-Star Holding Co., Ltd.) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati New Era Helium Inc NUAI|Narxning foydaga nisbati Bolt Projects Holdings (BSLK)|bionexusgenelab.com - Narx-foyda multiplikatori|Narxning foydaga nisbati Gulf Resources GURE|CN Energy Group Inc. (CNEY) - Kapitalizatsiyaning foydaga nisbati|ALTM - Narxning foydaga nisbati|Danimer Scientific, Inc (DNMR) - Narx-foyda koeffitsiyenti|GLT: P/E multiplikatori|GRFX - Biznesning o‘zini qoplash muddati|SLCA (U.S. Silica) - P/E multiplikatori|Narx-foyda koeffitsiyenti Invizyne Technologies Inc (IZTC)
